It would be a revolution for the whole world: this company wants to test an oral vaccine against the coronavirus

Steph Deschamps / July 24, 2021

 



According to the Jerusalem Post newspaper, Israel is poised to become the first country to test an oral coronavirus vaccine. The company Oravax Medical is currently awaiting approval from the Israeli Ministry of Health. A response from the Ministry of Health is expected in the next few weeks.

 
According to Nadav Kidron, head of parent company Oramed Pharmaceuticals, this coronavirus vaccine must first be tested on 24 volunteers who have not received any other vaccine. Half of this group will take one pill, the other half two. Then it will be examined how many antibodies are produced.
 
Kidron sees all sorts of advantages in developing a vaccine that people can swallow. It would no longer require professionals to administer it, and the product could be widely distributed. People might even be able to take their vaccine at home.
 
The company has already had several thousand pills produced that can be used in research. According to Kidron, the goal is to demonstrate that the concept is feasible.
 
I pray and hope that it will succeed. Imagine if people were vaccinated after we gave them an oral vaccine, says the senior official, it would be a revolution for the whole world.
      HTML Image as link                              

Related Posts

New Zealander gets 10 Covid shots in ONE day: investigation launched
New Zealander gets 10 Covid shots in ONE day: investigation launched
Steph Deschamps / December 11, 2021 New Zealand health authorities have launched an investigation after a man got th...
Read More
Vaccination for 5- to 11-year-olds: Italy gives green light to Pfizer vaccine
Vaccination for 5- to 11-year-olds: Italy gives green light to Pfizer vaccine
Sylvie Claire / December 2, 2021 Children aged 5 to 11 years will be able to receive one third of the dose given to...
Read More
Omicron variant poses very high risk globally, says WHO
Omicron variant poses very high risk globally, says WHO
Sylvie Claire / November 29, 2021 The new Omicron variant of the coronavirus presents a very high risk at the global...
Read More